In a similar fashion, it was demonstrated that DNMT3B bonded to the BECN1 promoter, causing an increase in DNA methylation and a decrease in protein expression in tamoxifen-resistant breast cancer (MCF7/TAMR) cells. The gene discussed is DNMT3B; the disease is breast carcinoma.